drugset / Trial / NCT03057314
Improving Function,Welfare of Late-stage Cancer Subjects by ACC
NaSingle-groupOpen-labelTreatment
Summary
To improve the function and welfare of late stage solid cancer subjects by: * enabling subjects to benefit from a potentially promising drug under development * assessing initial evidence of improvement in Pain VAS score * assessing initial improvement in Performance Status (PS) * assessing initial improvement in oxygen saturation whenever it is feasible
Timeline
- Start
- 2017-06-25
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
Outcome
Outcome not reported
Stopped: “Slow recreuitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amorphous Calcium Carbonate | Unknown | 1 % | Oral |
| Subject | Amorphous Calcium Carbonate | Unknown | 200 mg | Oral |